Literature DB >> 8431516

Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes.

J Haensler1, F C Szoka.   

Abstract

We have synthesized three bisacridine intercalators containing a galactose residue(s) to target DNA to cell surface receptors for use in gene-delivery systems. Each of the bisacridines could intercalate into DNA with micromolar dissociation constants. Bisacridines containing a single galactose on either a three- or six-carbon spacer from the secondary amine of spermidine-bisacridine could mediate binding of DNA to the soluble galactose receptor Ricinus communis lectin (RCA I), but not to the asialoglycoprotein receptor on primary hepatocytes. A trigalactosyl dilysyl bisacridine [(Gal-6)3Lys2-bA] compound could mediate the binding of DNA to both the ricin lectin and to primary hepatocytes. Binding of the (Gal-6)3Lys2-bA-DNA to the hepatocytes could be blocked by asialoorosomucoid. On the basis of luciferase expression, (Gal-6)3Lys2-bA did not induce transfection of the hepatocytes when attached to the pCLUC4 plasmid encoding the firefly luciferase gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431516     DOI: 10.1021/bc00019a012

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  10 in total

1.  Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.

Authors:  E A Biessen; H Vietsch; E T Rump; K Fluiter; J Kuiper; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 2.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

3.  Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes.

Authors:  Christian A Fernandez; Nicholas J Baumhover; Kevin Anderson; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

4.  In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex.

Authors:  H E Hofland; D Nagy; J J Liu; K Spratt; Y L Lee; O Danos; S M Sullivan
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 5.  Glycotargeting to improve cellular delivery efficiency of nucleic acids.

Authors:  Hongbin Yan; Kha Tram
Journal:  Glycoconj J       Date:  2007-02-01       Impact factor: 2.916

6.  N-glycan targeted gene delivery to the dendritic cell SIGN receptor.

Authors:  Kevin Anderson; Christian Fernandez; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-08-18       Impact factor: 4.774

7.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.

Authors:  J S Remy; A Kichler; V Mordvinov; F Schuber; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides.

Authors:  Nicholas J Baumhover; Kevin Anderson; Christian A Fernandez; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

9.  Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.

Authors:  C A Fernandez; N J Baumhover; J T Duskey; S Khargharia; K Kizzire; M D Ericson; K G Rice
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

Review 10.  Nano-vectors for efficient liver specific gene transfer.

Authors:  Atul Pathak; Suresh P Vyas; Kailash C Gupta
Journal:  Int J Nanomedicine       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.